Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company focused on improving patient lives by developing and commercializing products across a range of therapies. It has three commercially available products: Recorlev, Gvoke, and Keveyis. Recorlev is for the treatment of endogenous Cushing’s syndrome. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is a therapy for primary periodic paralysis. It also has a pipeline of development programs led by XP-8121, a phase III-ready, once-weekly subcutaneous injection for hypothyroidism. It is pursuing formulation and development partnerships to apply its XeriSol and XeriJect formulation technologies to enhance the drug delivery and clinical profile of other companies’ proprietary drugs and biologics. Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
Find out what a historical investment in XERIS BIOPHARMA HOLDINGS INC would be worth today using our XERS stock calculator.
Buying XERS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in XERIS BIOPHARMA HOLDINGS INC in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in XERS
What is the ticker symbol of XERIS BIOPHARMA HOLDINGS INC?
The ticker symbol for XERIS BIOPHARMA HOLDINGS INC is XERS.
How much is one share of XERS?
One share of XERS is valued at $16.62 as of 20 November 2026.
What is the market capitalisation of XERIS BIOPHARMA HOLDINGS INC XERS?
As of 20 November 2026 XERIS BIOPHARMA HOLDINGS INC has a market cap of $3.10B.
What is the 52-week high for XERIS BIOPHARMA HOLDINGS INC stock?
The XERIS BIOPHARMA HOLDINGS INC 52-week high stock price is $17.28.
What is the 52-week low for XERIS BIOPHARMA HOLDINGS INC stock?
The XERIS BIOPHARMA HOLDINGS INC 52-week low stock price is $5.25.
Can I buy XERS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy XERS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in XERS on Stake
Buy XERS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of XERS from only US$10 with fractional shares